The Obama administration has decided to extend bonus payments meant to reward top-quality Medicare Advantage plans to those performing at average quality levels, and provide larger bonuses to top performers.
The Obama administration has decided to extend bonus payments meant to reward top-quality Medicare Advantage plans to those performing at average quality levels, and provide larger bonuses to top performers. The move is intended to motivate low-performing plans to improve more quickly.
The Patient Protection and Affordable Care Act builds in an average 17% rate cut over the next several years for Medicare Advantage plans, which shrinks the total payments by more than $132 billion over 10 years. It also increases operational costs as a result of compliance and reporting requirements.
The healthcare reform law calls for rewarding plans that receive at least four out of five stars on quality measurements with bonuses of 1.5%, 3% and 5% in 2012, 2013 and 2014, respectively. However, the administration has extended the bonuses to plans that score at least three out of five stars, which include 62% of insurers. The bonuses begin in 2012. It will also reward five-star plans with an immediate 5% bonus in 2012, and four-star plans with a 4% bonus in 2012, instead of using the annual stepped bonus percentages.
The change was made by Medicare officials without congressional approval via a demonstration project.
For more on the changes to the Medicare Advantage plans, read Tidal Shift.
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More